{"id":113311,"date":"2021-04-30T22:31:11","date_gmt":"2021-04-30T22:31:11","guid":{"rendered":"https:\/\/fin2me.com\/?p=113311"},"modified":"2021-04-30T22:31:11","modified_gmt":"2021-04-30T22:31:11","slug":"who-gives-emergency-use-listing-to-modernas-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/","title":{"rendered":"WHO gives emergency use listing to Moderna's COVID-19 vaccine"},"content":{"rendered":"
FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS\/Mike Segar<\/figcaption>

ZURICH (Reuters) – The World Health Organization has listed Moderna\u2019s COVID-19 vaccine for emergency use, the agency said on Friday, the fifth to be given the status meant to expedite countries\u2019 own approval of shots.<\/p>\n

\u201cThe objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency,\u201d the WHO said in a statement.<\/p>\n

WHO Assistant Director-General Mariangela Simao said on Friday it was important to have more vaccines available because of supply problems for other shots, including from India, a main source of vaccines for the global COVAX vaccine sharing programme. India has restricted exports because of a crisis of infections.<\/p>\n

Moderna announced this week an expansion plan for its production network to boost its capacity to up to 3 billion doses in 2022.<\/p>\n

The WHO\u2019s Strategic Advisory Group of Experts on Immunization (SAGE) already in January had recommended Moderna\u2019s vaccine for all age groups 18 and above.<\/p>\n

Pfizer and its German partner BionTech\u2019s shot, also an mRNA vaccine like Moderna\u2019s, was the first vaccine to get a WHO emergency use listing in the final hours of 2020.<\/p>\n

Since then, the WHO has added vaccines from Astrazeneca-SK Bio, Serum Institute of India and Johnson & Johnson vaccines to the list.<\/p>\n

The Geneva-based health organization is still considering COVID-19 vaccines from Sinopharm and Sinovac following an extended review, with decisions due by the end of next week.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the […]<\/p>\n","protected":false},"author":3,"featured_media":113310,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nWHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me\" \/>\n<meta property=\"og:description\" content=\"FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-30T22:31:11+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/04\/WHO-gives-emergency-use-listing-to-Modernas-COVID-19-vaccine.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/\",\"url\":\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/\",\"name\":\"WHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-04-30T22:31:11+00:00\",\"dateModified\":\"2021-04-30T22:31:11+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"WHO gives emergency use listing to Moderna's COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"WHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me","og_description":"FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the [...]","og_url":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/","og_site_name":"Fin2me","article_published_time":"2021-04-30T22:31:11+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/04\/WHO-gives-emergency-use-listing-to-Modernas-COVID-19-vaccine.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/","url":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/","name":"WHO gives emergency use listing to Moderna's COVID-19 vaccine - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-04-30T22:31:11+00:00","dateModified":"2021-04-30T22:31:11+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/who-gives-emergency-use-listing-to-modernas-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"WHO gives emergency use listing to Moderna's COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/113311"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=113311"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/113311\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/113310"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=113311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=113311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=113311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}